Thomas W. Davis
Geisinger Medical Center(US)Geisinger Health System(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, Adolescent and Pediatric Healthcare, DNA Repair Mechanisms
Most-Cited Works
- → Self-renewal as a therapeutic target in human colorectal cancer(2013)532 cited
- → System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection(2019)204 cited
- Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11.(2002)
- Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.(1998)
- Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.(2002)
- → BMI1 as a novel target for drug discovery in cancer(2011)135 cited
- → Synergy between Celecoxib and Radiotherapy Results from Inhibition of Cyclooxygenase-2-Derived Prostaglandin E2, a Survival Factor for Tumor and Associated Vasculature(2004)106 cited
- → The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells